Ziopharm Oncology buy DomRuinart
Start price
03.05.21
/
50%
€2.72
Target price
03.05.22
€5.00
Performance (%)
-5.88%
End price
17.05.21
€2.56
Summary
This prediction ended on 17.05.21 with a price of €2.56. With a performance of -5.88%, the BUY prediction by DomRuinart finished with a loss. DomRuinart has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Ziopharm Oncology | - | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
According to DomRuinart what are the pros and cons of Ziopharm Oncology for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread Ziopharm Oncology diskutieren
Buy mit Kursziel 5,0
In the thread Trading Ziopharm Oncology
Buy beendet
Stopped prediction by DomRuinart for Ziopharm Oncology
Ziopharm Oncology
Start price
Target price
Perf. (%)
€2.44
31.05.21
31.05.21
€4.00
31.05.22
31.05.22
-2.46%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Ziopharm Oncology
Start price
Target price
Perf. (%)
€2.62
19.04.21
19.04.21
€4.00
19.04.22
19.04.22
3.82%
03.05.21
03.05.21
Could be worthwhile Investment >10% per year